BHVN Q4 2024 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$190M

Net Income

-$187M

EPS (Diluted)

$-1.85

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$171M

Free Cash Flow

-$171M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$615M

Total Liabilities

$192M

Stockholders' Equity

$423M

Cash & Equivalents

$99M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$948,000	+100.0%
Operating Income	-$190M	-$154M	-23.6%
Net Income	-$187M	-$145M	-29.1%